A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema

NCT01100307 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema
Diabetic Mellitus
Retinal Disease

Interventions

DRUG: pegaptanib sodium
OTHER: sham injection

Sponsor

Pfizer